Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Medical Devices

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp

Bullboard Posts

Post by elgin1on Dec 12, 2020 10:26pm

228 Views

Post# 32094646

ALL ROADS LEAD to NASDAQ

Folks for Sernova to succced, we need to list on Nasdaq ASAP. Abcellera a Vancouver Bioteck company debuted on Nasdaq yesterday . It closed 300% above its ipo price of $20 and closed at $60.with a $15 Billion dollar valuation . Siligon debuted at $840 million US market cap two days ago . Sgtx is very similar to Sva in many aspects . Axstra Zenica bought Alexicor for $39 billion ..45% premium to its share price of $145 per share .

Sva is going nowhere on the Veture . IpSva must be listed on Nasdaq period ! Trillium is where sits at now because it is on the Nasdaq. Either management get the share price high enough to qualify to list via news collaborations or do a roll back, but something has to be done.

https://www.bloomberg.com/news/articles/2020-12-11/thiel-backed-developer-of-covid-19-treatment-triples-after-ipo

To eventually get an excellent valuation for a potential buyout by pharma , it has to be reflected in its current share price. This is not going to happpen on the Venture exchange imo.

Elgin